Cargando…
Enhanced anti-melanoma efficacy through a combination of the armed oncolytic adenovirus ZD55-IL-24 and immune checkpoint blockade in B16-bearing immunocompetent mouse model
Although the recent treatment in melanoma through the use of anti-PD-1 immunotherapy is successful, the efficacy of this approach remains to be improved. Here, we explore the feasibility of combination strategy with the armed oncolytic adenovirus ZD55-IL-24 and PD-1 blockade. We find that combinatio...
Autores principales: | Hu, Hai-Jun, Liang, Xiu, Li, Hai-Lang, Wang, Huai-Yuan, Gu, Jin-Fa, Sun, Lan-Ying, Xiao, Jing, Hu, Jin-Qing, Ni, Ai-Min, Liu, Xin-Yuan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8571158/ https://www.ncbi.nlm.nih.gov/pubmed/33903973 http://dx.doi.org/10.1007/s00262-021-02946-z |
Ejemplares similares
-
The armed oncolytic adenovirus ZD55-IL-24 eradicates melanoma by turning the tumor cells from the self-state into the nonself-state besides direct killing
por: Hu, Hai-Jun, et al.
Publicado: (2020) -
Combination of oncolytic adenovirus ZD55 harboring TRAIL-IETD-MnSOD and cytokine-induced killer cells against lung cancer
por: Jiang, Runde, et al.
Publicado: (2021) -
Oncolytic adenoviruses expressing checkpoint inhibitors for cancer therapy
por: Xie, Daoyuan, et al.
Publicado: (2023) -
"Arming" the chimeric oncolytic adenovirus enadenotucirev to deliver checkpoint inhibitors and other therapeutics directly to tumours
por: Champion, Brian R, et al.
Publicado: (2014) -
HCCS1-armed, quadruple-regulated oncolytic adenovirus specific for liver cancer as a cancer targeting gene-viro-therapy strategy
por: Xu, Hai-Neng, et al.
Publicado: (2011)